GKOS - Glaukos Corporation
NEXT EARNINGS:
May 6, 2026
EPS Est: $-0.27
|
Rev Est: $137.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$143.44
DETAILS
HIGH:
$165.00
LOW:
$127.00
MEDIAN:
$145.00
CONSENSUS:
$143.44
UPSIDE:
20.37%
Market Cap:
6.84B
Volume:
444,160
Avg Volume:
883,795
52 Week Range:
73.16-130.69
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.70
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
995
IPO Date:
2015-06-25
EPS (TTM):
-3.28
P/E Ratio:
-34.40
Revenue (TTM):
507.44M
Total Assets:
893.49M
Total Debt:
139.64M
Cash & Equiv:
90.81M
Rev Growth (5Y):
17.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-25.2%
Debt/Equity:
0.21
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-17 | $-0.28 | $-0.22 | -27.3% | $143.1M | $134.3M | +6.5% |
| 2025-10-29 | $-0.16 | $-0.27 | +40.7% | $133.5M | $129.5M | +3.2% |
| 2025-07-30 | $-0.24 | $-0.26 | +7.7% | $124.1M | $122.4M | +1.4% |
| 2025-04-30 | $-0.22 | $-0.33 | +33.3% | $106.7M | $102.8M | +3.8% |
| 2025-02-20 | $-0.40 | $-0.38 | -5.3% | $105.5M | $101.0M | +4.5% |
| 2024-11-04 | $-0.28 | $-0.52 | +46.2% | $96.7M | $100.5M | -3.8% |
| 2024-07-31 | $-0.52 | $-0.52 | 0.0% | $95.7M | $88.9M | +7.6% |
| 2024-05-01 | $-0.70 | $-0.58 | -20.7% | $85.6M | $79.6M | +7.6% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 507.44M | 383.48M | 314.71M | 282.86M | 294.01M | 224.96M | 236.98M | 181.28M | 159.25M | 114.40M | 71.70M | 45.59M |
| Net Income | (187.69M) | (146.37M) | (134.66M) | (99.19M) | (49.59M) | (120.35M) | 15.42M | (12.95M) | (92,000) | 4.52M | (37.24M) | (12.13M) |
| EPS | -3.28 | -2.77 | -2.78 | -2.09 | -1.07 | -2.70 | 0.41 | -0.37 | -0.00 | 0.14 | -2.13 | -0.49 |
| Total Assets | 893.49M | 974.76M | 940.41M | 1.07B | 1.13B | 1.01B | 818.40M | 206.97M | 165.84M | 134.37M | 116.66M | 26.02M |
| Total Debt | 139.64M | 105.87M | 383.74M | 382.91M | 383.38M | 272.00M | 72.63M | 0 | 0 | 0 | 9.70M | 19.35M |
| Cash & Equivalents | 90.81M | 169.63M | 93.47M | 119.53M | 100.71M | 96.60M | 62.43M | 29.82M | 24.51M | 6.49M | 21.57M | 2.30M |
| Operating Cash Flow | (46.34M) | (61.32M) | (57.76M) | (33.08M) | 24.71M | (22.99M) | (369,000) | 18.86M | 25.51M | 12.31M | (2.19M) | (7.11M) |
| Free Cash Flow | (54.01M) | (67.62M) | (78.01M) | (63.35M) | (23.08M) | (29.92M) | (5.09M) | 8.55M | 19.20M | 6.03M | (3.06M) | (7.97M) |
| FCF per Share | -0.94 | -1.28 | -1.61 | -1.34 | -0.50 | -0.67 | -0.14 | 0.24 | 0.56 | 0.18 | -0.18 | -0.32 |
| Book Value | 656.15M | 766.93M | 461.77M | 530.00M | 587.15M | 667.45M | 673.27M | 173.86M | 138.20M | 117.27M | 95.19M | (151.30M) |
| Cash & ST Investments | 278.76M | 318.92M | 295.43M | 352.69M | 414.05M | 404.37M | 173.98M | 140.49M | 119.01M | 95.76M | 91.12M | 2.30M |
| ROC Equity | -0.29 | -0.19 | -0.29 | -0.19 | -0.08 | -0.18 | 0.02 | -0.07 | -0.00 | 0.04 | -0.39 | N/A |